{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Nrf2", "acetovanillone", "cardiotoxicity", "chemotherapy", "edaravone", "mTOR", "oxidative stress"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "33299300", "DateCompleted": {"Year": "2021", "Month": "09", "Day": "21"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "18"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "11", "Day": "30"}], "Language": ["eng"], "ELocationID": ["10.2147/DDDT.S281854"], "Journal": {"ISSN": "1177-8881", "JournalIssue": {"Volume": "14", "PubDate": {"Year": "2020"}}, "Title": "Drug design, development and therapy", "ISOAbbreviation": "Drug Des Devel Ther"}, "ArticleTitle": "Edaravone and Acetovanillone Upregulate Nrf2 and PI3K/Akt/mTOR Signaling and Prevent Cyclophosphamide Cardiotoxicity in Rats.", "Pagination": {"StartPage": "5275", "EndPage": "5288", "MedlinePgn": "5275-5288"}, "Abstract": {"AbstractText": ["Cyclophosphamide (CP) causes redox imbalance and its use is associated with marked cardiotoxicity that limits its clinical applications. The present study investigated the protective effects of acetovanillone (AV) and edaravone (ED) against CP-induced oxidative stress and cardiac damage, emphasizing the role of PI3K/Akt/mTOR and Nrf2 signaling.", "Rats received either AV (100 mg/kg) or ED (20 mg/kg) orally for 10 days and CP (200 mg/kg) on day 7. At day 11, the rats were sacrificed, and samples were collected for analysis.", "AV and ED ameliorated serum troponin I, CK-MB, LDH, AST and ALP, and prevented cardiac histological alterations in CP-intoxicated rats. Both treatments decreased cardiac lipid peroxidation and enhanced GSH, SOD and cytoglobin in CP-induced rats. AV and ED downregulated Keap1, whereas increased the expression of PI3K, Akt, mTOR and Nrf2 in the heart of rats received CP. Additionally, the binding modes of AV and ED to Keap1 were pinpointed in silico using molecular docking simulations.", "AV and ED prevent CP cardiotoxicity by attenuating oxidative stress and tissue injury, and modulating cytoglobin, and PI3K/Akt/mTOR and Keap1/Nrf2 signaling. Therefore, AV and ED may represent promising agents that can prevent cardiac injury in patients receiving CP."], "CopyrightInformation": "\u00a9 2020 Hassanein et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology Faculty of Pharmacy, Al-Azhar University, Assiut, Egypt."}], "LastName": "Hassanein", "ForeName": "Emad H M", "Initials": "EHM"}, {"Identifier": ["0000-0002-0349-7193"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Faculty of Pharmacy, Nahda University, Beni-Suef, Egypt."}], "LastName": "Abd El-Ghafar", "ForeName": "Omnia A M", "Initials": "OAM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Faculty of Medicine, Assiut University, Assiut, Egypt."}], "LastName": "Ahmed", "ForeName": "Marwa A", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biochemistry Laboratory, Chemistry Department, Faculty of Science, Assiut University, Assiut, Egypt."}], "LastName": "Sayed", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Human Anatomy & Embryology Department Faculty of Medicine, Al-Azhar University, Assiut, Egypt."}], "LastName": "Gad-Elrab", "ForeName": "Wail M", "Initials": "WM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Zoology Department, College of Science, King Saud University, Riyadh, Saudi Arabia."}], "LastName": "Ajarem", "ForeName": "Jamaan S", "Initials": "JS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Zoology Department Faculty of Science, Beni-Suef University, Beni-Suef, Egypt."}], "LastName": "Allam", "ForeName": "Ahmed A", "Initials": "AA"}, {"Identifier": ["0000-0003-0279-6500"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Zoology Department Faculty of Science, Beni-Suef University, Beni-Suef, Egypt."}, {"Identifier": [], "Affiliation": "Biotechnology Department, Research Institute of Medicinal and Aromatic Plants, Beni-Suef University, Beni-Suef, Egypt."}], "LastName": "Mahmoud", "ForeName": "Ayman M", "Initials": "AM"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Drug Des Devel Ther", "NlmUniqueID": "101475745", "ISSNLinking": "1177-8881"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Acetophenones"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-E2-Related Factor 2"}, {"RegistryNumber": "0", "NameOfSubstance": "Nfe2l2 protein, rat"}, {"RegistryNumber": "8N3DW7272P", "NameOfSubstance": "Cyclophosphamide"}, {"RegistryNumber": "B6J7B9UDTR", "NameOfSubstance": "acetovanillone"}, {"RegistryNumber": "EC 2.7.1.1", "NameOfSubstance": "mTOR protein, rat"}, {"RegistryNumber": "EC 2.7.1.137", "NameOfSubstance": "Phosphatidylinositol 3-Kinase"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Proto-Oncogene Proteins c-akt"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "TOR Serine-Threonine Kinases"}, {"RegistryNumber": "S798V6YJRP", "NameOfSubstance": "Edaravone"}], "MeshHeadingList": [{"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Acetophenones"}, {"QualifierName": [], "DescriptorName": "Administration, Oral"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Antioxidants"}, {"QualifierName": [], "DescriptorName": "Cyclophosphamide"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Edaravone"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["chemically induced", "prevention & control"], "DescriptorName": "Myocardial Reperfusion Injury"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-E2-Related Factor 2"}, {"QualifierName": ["metabolism"], "DescriptorName": "Phosphatidylinositol 3-Kinase"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-akt"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["metabolism"], "DescriptorName": "TOR Serine-Threonine Kinases"}, {"QualifierName": ["drug effects"], "DescriptorName": "Up-Regulation"}], "CoiStatement": "The authors declare that there are no potential conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Moignet A, Hasanali Z, Zambello R, et al. Cyclophosphamide as a first-line therapy in LGL leukemia. Leukemia. 2014;28(5):1134\u20131136. doi:10.1038/leu.2013.359", "ArticleIdList": ["10.1038/leu.2013.359", "PMC4017255", "24280867"]}, {"Citation": "Stork CM, Schreffler SM. Cyclophosphamide In: Wexler P, editor. Encyclopedia of Toxicology (Third Edition). Oxford: Academic Press; 2014:1111\u20131113."}, {"Citation": "Iqubal A, Iqubal MK, Sharma S, et al. Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: old drug with a new vision. Life Sci. 2019;218:112\u2013131. doi:10.1016/j.lfs.2018.12.018", "ArticleIdList": ["10.1016/j.lfs.2018.12.018", "30552952"]}, {"Citation": "Kurauchi K, Nishikawa T, Miyahara E, Okamoto Y, Kawano Y. Role of metabolites of cyclophosphamide in cardiotoxicity. BMC Res Notes. 2017;10(1):406. doi:10.1186/s13104-017-2726-2", "ArticleIdList": ["10.1186/s13104-017-2726-2", "PMC5557551", "28807058"]}, {"Citation": "Shanholtz C. Acute life-threatening toxicity of cancer treatment. Crit Care Clin. 2001;17(3):483\u2013502. doi:10.1016/S0749-0704(05)70196-2", "ArticleIdList": ["10.1016/S0749-0704(05)70196-2", "11529252"]}, {"Citation": "Morandi P, Ruffini PA, Benvenuto GM, La Vecchia L, Mezzena G, Raimondi R. Serum cardiac troponin I levels and ECG/echo monitoring in breast cancer patients undergoing high-dose (7 g/m(2)) cyclophosphamide. Bone Marrow Transplant. 2001;28(3):277\u2013282. doi:10.1038/sj.bmt.1703132", "ArticleIdList": ["10.1038/sj.bmt.1703132", "11535996"]}, {"Citation": "Braverman AC, Antin JH, Plappert MT, Cook EF, Lee RT. Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens. J Clin Oncol. 1991;9(7):1215\u20131223. doi:10.1200/JCO.1991.9.7.1215", "ArticleIdList": ["10.1200/JCO.1991.9.7.1215", "2045862"]}, {"Citation": "Aladaileh SH, Abukhalil MH, Saghir SAM, et al. Galangin activates Nrf2 signaling and attenuates oxidative damage, inflammation, and apoptosis in a rat model of cyclophosphamide-induced hepatotoxicity. Biomolecules. 2019;9(8):346. doi:10.3390/biom9080346", "ArticleIdList": ["10.3390/biom9080346", "PMC6723184", "31387329"]}, {"Citation": "ALHaithloul HAS, Alotaibi MF, Bin-Jumah M, Elgebaly H, Mahmoud AM. Olea europaea leaf extract up-regulates Nrf2/ARE/HO-1 signaling and attenuates cyclophosphamide-induced oxidative stress, inflammation and apoptosis in rat kidney. Biomed Pharmacother. 2019;111:676\u2013685. doi:10.1016/j.biopha.2018.12.112", "ArticleIdList": ["10.1016/j.biopha.2018.12.112", "30611992"]}, {"Citation": "Kamel EM, Mahmoud AM, Ahmed SA, Lamsabhi AM. A phytochemical and computational study on flavonoids isolated from Trifolium resupinatum L. and their novel hepatoprotective activity. Food Funct. 2016;7(4):2094\u20132106. doi:10.1039/C6FO00194G", "ArticleIdList": ["10.1039/C6FO00194G", "27053086"]}, {"Citation": "Mahmoud AM, Germoush MO, Alotaibi MF, Hussein OE. Possible involvement of Nrf2 and PPAR\u03b3 up-regulation in the protective effect of umbelliferone against cyclophosphamide-induced hepatotoxicity. Biomed Pharmacother. 2017;86:297\u2013306. doi:10.1016/j.biopha.2016.12.047", "ArticleIdList": ["10.1016/j.biopha.2016.12.047", "28011377"]}, {"Citation": "Moghe A, Ghare S, Lamoreau B, et al. Molecular mechanisms of acrolein toxicity: relevance to human disease. Toxicol Sci. 2015;143(2):242\u2013255. doi:10.1093/toxsci/kfu233", "ArticleIdList": ["10.1093/toxsci/kfu233", "PMC4306719", "25628402"]}, {"Citation": "Satta S, Mahmoud AM, Wilkinson FL, Yvonne Alexander M, White SJ. The role of Nrf2 in cardiovascular function and disease. Oxid Med Cell Longev. 2017;2017:9237263. doi:10.1155/2017/9237263", "ArticleIdList": ["10.1155/2017/9237263", "PMC5618775", "29104732"]}, {"Citation": "Zeng J, Zhao H, Chen B. DJ-1/PARK7 inhibits high glucose-induced oxidative stress to prevent retinal pericyte apoptosis via the PI3K/AKT/mTOR signaling pathway. Exp Eye Res. 2019;189:107830. doi:10.1016/j.exer.2019.107830", "ArticleIdList": ["10.1016/j.exer.2019.107830", "31593688"]}, {"Citation": "Wang X, Pan J, Liu D, et al. Nicorandil alleviates apoptosis in diabetic cardiomyopathy through PI3K/Akt pathway. J Cell Mol Med. 2019;23(8):5349\u20135359. doi:10.1111/jcmm.14413", "ArticleIdList": ["10.1111/jcmm.14413", "PMC6653072", "31131539"]}, {"Citation": "Sciarretta S, Volpe M, Sadoshima J. Mammalian target of rapamycin signaling in cardiac physiology and disease. Circ Res. 2014;114(3):549\u2013564. doi:10.1161/CIRCRESAHA.114.302022", "ArticleIdList": ["10.1161/CIRCRESAHA.114.302022", "PMC3995130", "24481845"]}, {"Citation": "Sun Y, Gong F, Yin J, et al. Therapeutic effect of apocynin through antioxidant activity and suppression of apoptosis and inflammation after spinal cord injury. Exp Ther Med. 2017;13(3):952\u2013960. doi:10.3892/etm.2017.4090", "ArticleIdList": ["10.3892/etm.2017.4090", "PMC5403360", "28450925"]}, {"Citation": "Kapoor M, Sharma N, Sandhir R, Nehru B. Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion hippocampus injury in rat brain. Biomed Pharmacother. 2018;97:458\u2013472. doi:10.1016/j.biopha.2017.10.123", "ArticleIdList": ["10.1016/j.biopha.2017.10.123", "29091896"]}, {"Citation": "Francis S, Laurieri N, Nwokocha C, Delgoda R. Treatment of rats with apocynin has considerable inhibitory effects on arylamine N-acetyltransferase activity in the liver. Sci Rep. 2016;6:26906. doi:10.1038/srep26906", "ArticleIdList": ["10.1038/srep26906", "PMC4886258", "27242013"]}, {"Citation": "Gimenes R, Gimenes C, Rosa CM, et al. Influence of apocynin on cardiac remodeling in rats with streptozotocin-induced diabetes mellitus. Cardiovasc Diabetol. 2018;17(1):15.", "ArticleIdList": ["PMC5771187", "29343259"]}, {"Citation": "Hou L, Sun F, Huang R, Sun W, Zhang D, Wang Q. Inhibition of NADPH oxidase by apocynin prevents learning and memory deficits in a mouse Parkinson\u2019s disease model. Redox Biol. 2019;22:101134. doi:10.1016/j.redox.2019.101134", "ArticleIdList": ["10.1016/j.redox.2019.101134", "PMC6389731", "30798073"]}, {"Citation": "Tan YC, Abdul Sattar M, Ahmeda AF, et al. Apocynin and catalase prevent hypertension and kidney injury in Cyclosporine A-induced nephrotoxicity in rats. PLoS One. 2020;15(4):e0231472. doi:10.1371/journal.pone.0231472", "ArticleIdList": ["10.1371/journal.pone.0231472", "PMC7161975", "32298299"]}, {"Citation": "Homma T, Kobayashi S, Sato H, Fujii J. Edaravone, a free radical scavenger, protects against ferroptotic cell death in vitro. Exp Cell Res. 2019;384(1):111592. doi:10.1016/j.yexcr.2019.111592", "ArticleIdList": ["10.1016/j.yexcr.2019.111592", "31479686"]}, {"Citation": "Lin H, Ma X, Wang BC, et al. Edaravone ameliorates compression-induced damage in rat nucleus pulposus cells. Life Sci. 2017;189:76\u201383. doi:10.1016/j.lfs.2017.09.024", "ArticleIdList": ["10.1016/j.lfs.2017.09.024", "28942283"]}, {"Citation": "He F, Cao Y-P, Che F-Y, Yang L-H, Xiao S-H, Liu J. Inhibitory effects of edaravone in \u03b2-amyloid-induced neurotoxicity in rats. Biomed Res Int. 2014;2014:370368. doi:10.1155/2014/370368", "ArticleIdList": ["10.1155/2014/370368", "PMC3996961", "24804216"]}, {"Citation": "Tajima S, Bando M, Ishii Y, et al. Effects of edaravone, a free-radical scavenger, on bleomycin-induced lung injury in mice. Eur Respir J. 2008;32(5):1337\u20131343. doi:10.1183/09031936.00164407", "ArticleIdList": ["10.1183/09031936.00164407", "18614556"]}, {"Citation": "Basol N, Aygun H, Gul SS. Beneficial effects of edaravone in experimental model of amitriptyline-induced cardiotoxicity in rats. Naunyn Schmiedebergs Arch Pharmacol. 2019;392(11):1447\u20131453. doi:10.1007/s00210-019-01683-6", "ArticleIdList": ["10.1007/s00210-019-01683-6", "31273393"]}, {"Citation": "Liu J, Jiang Y, Zhang G, Lin Z, Du S. Protective effect of edaravone on blood-brain barrier by affecting NRF-2/HO-1 signaling pathway. Exp Ther Med. 2019;18(4):2437\u20132442.", "ArticleIdList": ["PMC6755265", "31555355"]}, {"Citation": "Shokrzadeh M, Chabra A, Naghshvar F, Ahmadi A, Jafarinejhad M, Hasani-Nourian Y. Protective effects of melatonin against cyclophosphamide-induced oxidative lung toxicity in mice. Drug Res. 2015;65(6):281\u2013286.", "ArticleIdList": ["24668577"]}, {"Citation": "Bancroft JD, Gamble M. Theory and Practice of Histological Techniques. Elsevier health sciences; 2008."}, {"Citation": "Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 1978;86(1):271\u2013278. doi:10.1016/0003-2697(78)90342-1", "ArticleIdList": ["10.1016/0003-2697(78)90342-1", "655387"]}, {"Citation": "Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82(1):70\u201377. doi:10.1016/0003-9861(59)90090-6", "ArticleIdList": ["10.1016/0003-9861(59)90090-6", "13650640"]}, {"Citation": "Marklund SL. Superoxide dismutase isoenzymes in tissues and plasma from New Zealand black mice, nude mice and normal BALB/c mice. Mutat Res. 1985;148(1\u20132):129\u2013134. doi:10.1016/0027-5107(85)90216-7", "ArticleIdList": ["10.1016/0027-5107(85)90216-7", "3969077"]}, {"Citation": "Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001;25(4):402\u2013408. doi:10.1006/meth.2001.1262", "ArticleIdList": ["10.1006/meth.2001.1262", "11846609"]}, {"Citation": "Trott O, Olson AJ. AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455\u2013461.", "ArticleIdList": ["PMC3041641", "19499576"]}, {"Citation": "Jnoff E, Albrecht C, Barker JJ, et al. Binding mode and structure-activity relationships around direct inhibitors of the Nrf2-Keap1 complex. ChemMedChem. 2014;9(4):699\u2013705. doi:10.1002/cmdc.201300525", "ArticleIdList": ["10.1002/cmdc.201300525", "24504667"]}, {"Citation": "Goldberg MA, Antin JH, Guinan EC, Rappeport JM. Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood. 1986;68(5):1114\u20131118. doi:10.1182/blood.V68.5.1114.1114", "ArticleIdList": ["10.1182/blood.V68.5.1114.1114", "3533179"]}, {"Citation": "Omole JG, Ayoka OA, Alabi QK, et al. Protective effect of kolaviron on cyclophosphamide-induced cardiac toxicity in rats. J Evid Based Integr Med. 2018;23:2156587218757649. doi:10.1177/2156587218757649", "ArticleIdList": ["10.1177/2156587218757649", "PMC5871040", "29468886"]}, {"Citation": "El-Sheikh AA, Abdelzaher WY, Gad AA, Abdel-Gaber SA. Purine versus non-purine xanthine oxidase inhibitors against cyclophosphamide-induced cardiac and bone marrow toxicity in rats. Hum Exp Toxicol. 2020;39(3):249\u2013261. doi:10.1177/0960327119883412", "ArticleIdList": ["10.1177/0960327119883412", "31640406"]}, {"Citation": "El-Sawalhi MM, Ahmed LA. Exploring the protective role of apocynin, a specific NADPH oxidase inhibitor, in cisplatin-induced cardiotoxicity in rats. Chem Biol Interact. 2014;207:58\u201366. doi:10.1016/j.cbi.2013.11.008", "ArticleIdList": ["10.1016/j.cbi.2013.11.008", "24291008"]}, {"Citation": "Saleem N, Prasad A, Goswami SK. Apocynin prevents isoproterenol-induced cardiac hypertrophy in rat. Mol Cell Biochem. 2018;445(1):79\u201388. doi:10.1007/s11010-017-3253-0", "ArticleIdList": ["10.1007/s11010-017-3253-0", "29256115"]}, {"Citation": "Koohsari M, Shaki F, Jahani D. Protective effects of edaravone against methamphetamine-induced cardiotoxicity. Braz Arch Biol Technol. 2016;59. doi:10.1590/1678-4324-2016160093", "ArticleIdList": ["10.1590/1678-4324-2016160093"]}, {"Citation": "Emekli-Alturfan E, Alev B, Tunali S, et al. Effects of edaravone on cardiac damage in valproic acid induced toxicity. Ann Clin Lab Sci. 2015;45(2):166\u2013172.", "ArticleIdList": ["25887870"]}, {"Citation": "Hassan MQ, Akhtar MS, Afzal O, et al. Edaravone and benidipine protect myocardial damage by regulating mitochondrial stress, apoptosis signalling and cardiac biomarkers against doxorubicin-induced cardiotoxicity. Clin Exp Hypertens. 2020;42(5):381\u2013392. doi:10.1080/10641963.2019.1676770", "ArticleIdList": ["10.1080/10641963.2019.1676770", "31630586"]}, {"Citation": "Smathers RL, Galligan JJ, Stewart BJ, Petersen DR. Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease. Chem Biol Interact. 2011;192(1\u20132):107\u2013112. doi:10.1016/j.cbi.2011.02.021", "ArticleIdList": ["10.1016/j.cbi.2011.02.021", "PMC3109208", "21354120"]}, {"Citation": "Mahmoud AM, Al Dera HS. 18\u03b2-glycyrrhetinic acid exerts protective effects against cyclophosphamide-induced hepatotoxicity: potential role of PPAR\u03b3 and Nrf2 upregulation. Genes Nutr. 2015;10(6):41. doi:10.1007/s12263-015-0491-1", "ArticleIdList": ["10.1007/s12263-015-0491-1", "PMC4575654", "26386843"]}, {"Citation": "Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87(10):840\u2013844. doi:10.1161/01.RES.87.10.840", "ArticleIdList": ["10.1161/01.RES.87.10.840", "11073878"]}, {"Citation": "Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med. 2000;192(7):1001\u20131014. doi:10.1084/jem.192.7.1001", "ArticleIdList": ["10.1084/jem.192.7.1001", "PMC2193314", "11015441"]}, {"Citation": "Brown DI, Griendling KK. Regulation of signal transduction by reactive oxygen species in the cardiovascular system. Circ Res. 2015;116(3):531\u2013549. doi:10.1161/CIRCRESAHA.116.303584", "ArticleIdList": ["10.1161/CIRCRESAHA.116.303584", "PMC4392388", "25634975"]}, {"Citation": "Li S, Wang W, Niu T, et al. Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction. Oxid Med Cell Longev. 2014;2014:748524. doi:10.1155/2014/748524", "ArticleIdList": ["10.1155/2014/748524", "PMC4033424", "24895528"]}, {"Citation": "Xing Y, Niu T, Wang W, et al. Triterpenoid dihydro-CDDO-trifluoroethyl amide protects against maladaptive cardiac remodeling and dysfunction in mice: a critical role of Nrf2. PLoS One. 2012;7(9):e44899. doi:10.1371/journal.pone.0044899", "ArticleIdList": ["10.1371/journal.pone.0044899", "PMC3444497", "23028668"]}, {"Citation": "Abd El-Twab SM, Hussein OE, Hozayen WG, Bin-Jumah M, Mahmoud AM. Chicoric acid prevents methotrexate-induced kidney injury by suppressing NF-kappaB/NLRP3 inflammasome activation and up-regulating Nrf2/ARE/HO-1 signaling. Inflamm Res. 2019;68(6):511\u2013523. doi:10.1007/s00011-019-01241-z", "ArticleIdList": ["10.1007/s00011-019-01241-z", "31037316"]}, {"Citation": "Mahmoud AM, Germoush MO, Al-Anazi KM, Mahmoud AH, Farah MA, Allam AA. Commiphora molmol protects against methotrexate-induced nephrotoxicity by up-regulating Nrf2/ARE/HO-1 signaling. Biomed Pharmacother. 2018;106:499\u2013509. doi:10.1016/j.biopha.2018.06.171", "ArticleIdList": ["10.1016/j.biopha.2018.06.171", "29990838"]}, {"Citation": "Mahmoud AM, Wilkinson FL, McCarthy EM, et al. Endothelial microparticles prevent lipid-induced endothelial damage via Akt/eNOS signaling and reduced oxidative stress. FASEB J. 2017;31(10):4636\u20134648. doi:10.1096/fj.201601244RR", "ArticleIdList": ["10.1096/fj.201601244RR", "PMC5714503", "28687612"]}, {"Citation": "Cruz-\u00c1lvarez S, Santana-Mart\u00ednez R, Avila-Ch\u00e1vez E, et al. Apocynin protects against neurological damage induced by quinolinic acid by an increase in glutathione synthesis and Nrf2 levels. Neuroscience. 2017;350:65\u201374. doi:10.1016/j.neuroscience.2017.03.011", "ArticleIdList": ["10.1016/j.neuroscience.2017.03.011", "28323011"]}, {"Citation": "Zhang M, Teng CH, Wu FF, et al. Edaravone attenuates traumatic brain injury through anti-inflammatory and anti-oxidative modulation. Exp Ther Med. 2019;18(1):467\u2013474.", "ArticleIdList": ["PMC6580098", "31281440"]}, {"Citation": "Shou L, Bei Y, Song Y, et al. Nrf2 mediates the protective effect of edaravone after chlorpyrifos-induced nervous system toxicity. Environ Toxicol. 2019;34(5):626\u2013633. doi:10.1002/tox.22728", "ArticleIdList": ["10.1002/tox.22728", "30758894"]}, {"Citation": "Yuan W, Chang H, Liu X, Wang S, Liu H, Xuan H. Brazilian green propolis inhibits Ox-LDL-stimulated oxidative stress in human umbilical vein endothelial cells partly through PI3K/Akt/mTOR-mediated Nrf2/HO-1 pathway. Evid Based Complement Alternat Med. 2019;2019:5789574. doi:10.1155/2019/5789574", "ArticleIdList": ["10.1155/2019/5789574", "PMC6642762", "31360208"]}, {"Citation": "Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149(2):274\u2013293. doi:10.1016/j.cell.2012.03.017", "ArticleIdList": ["10.1016/j.cell.2012.03.017", "PMC3331679", "22500797"]}, {"Citation": "Zhang D, Contu R, Latronico MV, et al. MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. J Clin Invest. 2010;120(8):2805\u20132816. doi:10.1172/JCI43008", "ArticleIdList": ["10.1172/JCI43008", "PMC2912201", "20644257"]}, {"Citation": "Tamai T, Yamaguchi O, Hikoso S, et al. Rheb (Ras homologue enriched in brain)-dependent mammalian target of rapamycin complex 1 (mTORC1) activation becomes indispensable for cardiac hypertrophic growth after early postnatal period. J Biol Chem. 2013;288(14):10176\u201310187. doi:10.1074/jbc.M112.423640", "ArticleIdList": ["10.1074/jbc.M112.423640", "PMC3617260", "23426372"]}, {"Citation": "Sancak Y, Thoreen CC, Peterson TR, et al. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell. 2007;25(6):903\u2013915. doi:10.1016/j.molcel.2007.03.003", "ArticleIdList": ["10.1016/j.molcel.2007.03.003", "17386266"]}, {"Citation": "Zhu W, Soonpaa MH, Chen H, et al. Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway. Circulation. 2009;119(1):99\u2013106. doi:10.1161/CIRCULATIONAHA.108.799700", "ArticleIdList": ["10.1161/CIRCULATIONAHA.108.799700", "PMC2630181", "19103993"]}, {"Citation": "Lee BS, Oh J, Kang SK, et al. Insulin protects cardiac myocytes from doxorubicin toxicity by Sp1-mediated transactivation of survivin. PLoS One. 2015;10(8):e0135438. doi:10.1371/journal.pone.0135438", "ArticleIdList": ["10.1371/journal.pone.0135438", "PMC4535909", "26271039"]}, {"Citation": "Albayrak G, Sonmez PK, Akogullari D, Uluer ET. Cyclophosphamide inhibits PI3K/AKT/mTOR signaling pathway in mice kidneys. Proceedings. 2018;2(25):1587. doi:10.3390/proceedings2251587", "ArticleIdList": ["10.3390/proceedings2251587"]}, {"Citation": "Ludemann J, Verissimo KM, Dreger K, Fago A, Schneider I, Burmester T. Globin E is a myoglobin-related, respiratory protein highly expressed in lungfish oocytes. Sci Rep. 2019;9(1):280. doi:10.1038/s41598-018-36592-w", "ArticleIdList": ["10.1038/s41598-018-36592-w", "PMC6343008", "30670817"]}, {"Citation": "Ou L, Li X, Chen B, et al. Recombinant human cytoglobin prevents atherosclerosis by regulating lipid metabolism and oxidative stress. J Cardiovasc Pharmacol Ther. 2018;23(2):162\u2013173. doi:10.1177/1074248417724870", "ArticleIdList": ["10.1177/1074248417724870", "28954528"]}, {"Citation": "Latina A, Viticchie G, Lena AM, et al. DeltaNp63 targets cytoglobin to inhibit oxidative stress-induced apoptosis in keratinocytes and lung cancer. Oncogene. 2016;35(12):1493\u20131503. doi:10.1038/onc.2015.222", "ArticleIdList": ["10.1038/onc.2015.222", "26096935"]}, {"Citation": "Zhang S, Li X, Jourd\u2019heuil FL, et al. Cytoglobin promotes cardiac progenitor cell survival against oxidative stress via the upregulation of the NFkappaB/iNOS signal pathway and nitric oxide production. Sci Rep. 2017;7(1):10754. doi:10.1038/s41598-017-11342-6", "ArticleIdList": ["10.1038/s41598-017-11342-6", "PMC5589853", "28883470"]}, {"Citation": "Xu HW, Huang YJ, Xie ZY, et al. The expression of cytoglobin as a prognostic factor in gliomas: a retrospective analysis of 88 patients. BMC Cancer. 2013;13:247. doi:10.1186/1471-2407-13-247", "ArticleIdList": ["10.1186/1471-2407-13-247", "PMC3663650", "23688241"]}, {"Citation": "Demirci S, Do\u011fan A, Apdik H, et al. Cytoglobin inhibits migration through PI3K/AKT/mTOR pathway in fibroblast cells. Mol Cell Biochem. 2018;437(1):133\u2013142. doi:10.1007/s11010-017-3101-2", "ArticleIdList": ["10.1007/s11010-017-3101-2", "28620820"]}]}], "History": [{"Year": "2020", "Month": "9", "Day": "17"}, {"Year": "2020", "Month": "11", "Day": "11"}, {"Year": "2020", "Month": "12", "Day": "10", "Hour": "5", "Minute": "56"}, {"Year": "2020", "Month": "12", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "11", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["33299300", "PMC7721127", "10.2147/DDDT.S281854", "281854"]}}]}